Kinetics of Human Erythrocyte Acetylcholinesterase Inhibition by a Novel Derivative of Physostigmine: Phenserine
- 9 July 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 248 (1) , 180-185
- https://doi.org/10.1006/bbrc.1998.8931
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Thermodynamic Investigation of Camel Retina Acetylcholinesterase Inhibition by CyclophosphamideJournal of Enzyme Inhibition, 1997
- The Preparation and Kinetic Analysis of Multiple Forms of Human Erythrocyte AcetylcholinesterasePreparative Biochemistry & Biotechnology, 1996
- Phenserine and ring C hetero‐analogues: Drug candidates for the treatment of Alzheimer's diseaseMedicinal Research Reviews, 1995
- Phenserine: a physostigmine derivative that is a long-acting inhibitor of cholinesterase and demonstrates a wide dose range for attenuating a scopolamine-induced learning impairment of rats in a 14-unit T-mazePsychopharmacology, 1993
- Cholinesterase inhibitor effects on extracellular acetylcholine in rat cortexNeuropharmacology, 1993
- General occurrence of binding to acetylcholinesterase-substrate complex in noncompetitive inhibition and in inhibition by substrateBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1991
- Mechanisms of cholinesterase inhibition in senile dementia of the alzheimer type: Clinical, pharmacological, and therapeutic aspectsDrug Development Research, 1988
- An Amphiphile‐Dependent Form of Human Brain Caudate Nucleus Acetylcholinesterase: Purification and PropertiesJournal of Neurochemistry, 1982
- PHYSOSTIGMINE IN ALZHEIMER'S DISEASEThe Lancet, 1979
- A new and rapid colorimetric determination of acetylcholinesterase activityBiochemical Pharmacology, 1961